Vaccines targeting adults, teens best chance to eliminate TB
Wednesday, October 8, 2014
Researchers at the London School of Hygiene & Tropical Medicine and the Stop TB Department at the World Health Organisation found that a vaccine given to adolescents and adults in low- and middle-income countries could have a much larger impact on the burden of TB worldwide and is more likely to be cost-effective, even if the vaccine has low efficacy and short duration or carries a high price.
TB mostly affects young adults and kills more than one million people every year, 95 per cent of whom are in low- and middle-income countries. The World Health Organisation has set the goal of eliminating TB by the year 2050.
The researchers used a mathematical model to estimate the impact and cost-effectiveness of a range of vaccination strategies in low- and middle-income countries.
- Health Care